Provayblue (methylene blue) is a small molecule pharmaceutical. Methylene blue was first approved as Provayblue on 2016-04-08. It is used to treat cyanosis, herpes simplex, lithiasis, methemoglobinemia, and poisoning amongst others in the USA.
|Common Name||Methylthioninium chloride|
|Indication||cyanosis, herpes simplex, lithiasis, methemoglobinemia, poisoning, urinary tract infections|